Advances in CAR-T therapy for central nervous system tumors
Abstract The application of chimeric antigen receptor T-cell therapy in central nervous system tumors has significantly advanced; however, challenges pertaining to the blood-brain barrier, immunosuppressive microenvironment, and antigenic heterogeneity continue to be encountered, unlike its success...
Saved in:
Main Authors: | Delian Zhou (Author), Xiaojian Zhu (Author), Yi Xiao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Central Nervous System Tumors
Published: (2022) -
Central Nervous System Tumors Primary and Secondary
Published: (2023) -
Tumors of the Central Nervous System Primary and Secondary
Published: (2014) -
Radon exposure and tumors of the central nervous system
by: Alberto Ruano-Ravina, et al.
Published: (2018) -
CENTRAL NERVOUS SYSTEM TUMORS IN CHILDHOOD AND ADOLESCENCE
by: Daniela Popeia
Published: (2009)